The counter receptor expressed on immune cells of B7H3 has not been identified yet, but it is conceivable that activated CD4+ and CD8+ T cells express a receptor interacting with APC cells or tumor cells through B7H3 and this interaction leads to inhibition of lymphocyte functions such as tumor cell killing and cytokine production (247–249). The gene discussed is CD4; the disease is neoplasm.